New Report Available: Global Parkinson's Disease Market 2014-2018

From: Fast Market Research, Inc.
Published: Thu Sep 11 2014

Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson's disease such as tremor, bradykinesia, and muscular rigidity. It is usually diagnosed in the population aged 60 and over; however, earlier incidences have been reported. Based on the severity, it can be categorized into early stage, mid stage and late (or advanced) stage. Currently, the approved therapies provide only symptomatic relief. Levodopa is the standard drug for the treatment of Parkinson's disease; however, it is associated with the incidence of dyskinesias. Alternative surgical procedures such as bilateral globus pallidus interna stimulation and bilateral subthalamic nucleus stimulation can be used in Parkinson's disease patients under certain circumstances.

Full Report Details at

TechNavio's analysts forecast the Global Parkinson's Disease market will grow at a CAGR of 3.32 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Parkinson's Disease market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various drugs administered to provide symptomatic relief in Parkinson's disease.

The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Parkinson's Disease market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the Global Parkinson's Disease Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

* Americas

Key Vendors

* Boehringer Ingelheim GmbH
* GlaxoSmithKline plc
* Novartis AG
* Teva Pharmaceutical Industries Ltd.

Other Prominent Vendors

* Abbvie Inc.
* Akorn Inc.
* Astellas Pharma Inc.
* Desitin Arzneimittel GmbH
* Endo International plc
* F. Hoffmann-La Roche Ltd.
* H. Lundbeck A/S
* Kyowa Hakko Kirin
* Merck & Co. Inc.
* Orion Corp.
* STADA Arzneimittel AG
* UCB Inc.
* US WorldMeds LLC
* Valeant Pharmaceuticals International Inc.

Key Market Driver

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013
- Sickle Cell Disease Global Clinical Trials Review, H2, 2013
- Huntington's Disease Global Clinical Trials Review, H2, 2013
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013
- Congenital Heart Disease Global Clinical Trials Review, H2, 2013
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »